接受抗逆转录病毒治疗者完整HIV前病毒DNA与复制 competent病毒频率的纵向动态
该研究对83名接受抗逆转录病毒治疗且病毒抑制的HIV感染者进行QVOA和IPDA检测,共156份静息CD4 T细胞样本,其中29人纵向随访。结果显示完整前病毒DNA频率与复制 competent病毒频率正相关,纵向下降趋势相似,而缺陷前病毒DNA频率相对稳定。IPDA有望作为高通量替代标志物评估复制 competent储存库变化。
要点
- 完整前病毒DNA频率与QVOA测得的复制 competent病毒频率正相关
- 纵向随访中完整前病毒DNA下降趋势与复制 competent病毒相似
- 缺陷前病毒DNA频率在多数个体中随时间相对稳定
核心结论
- IPDA衍生的完整前病毒DNA频率变化与QVOA测得的复制 competent HIV频率变化相似。
- IPDA是估计复制 competent储存库频率变化的有前景的高通量方法。
研究设计与样本
- 对83名抗逆转录病毒治疗抑制的HIV阳性参与者的156份静息CD4 T细胞样本进行QVOA和IPDA检测。
- 对其中29名参与者的静息CD4 T细胞进行纵向QVOA和IPDA检测。
主要发现
- 完整、缺陷和总前病毒频率与复制 competent HIV频率呈正相关。
- 纵向来看,大多数参与者中完整前病毒频率的下降与复制 competent病毒的下降惊人地相似。
- 相比之下,大多数个体中缺陷前病毒DNA频率随时间相对稳定。
临床怎么用
- IPDA可用于高通量评估抗逆转录病毒治疗下HIV复制 competent储存库的变化。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The replication-competent human immunodeficiency virus (HIV) reservoir is the major barrier to cure. The quantitative viral outgrowth assay (QVOA), the gold-standard method to quantify replication-competent HIV, is resource intensive, which limits its application in large clinical trials. The intact proviral DNA assay (IPDA) requires minimal cell input relative to QVOA and quantifies both defective and intact proviral HIV DNA, the latter potentially serving as a surrogate marker for replication-competent provirus. However, there are limited cross-sectional and longitudinal data on the relationship between IPDA and QVOA measurements. METHODS: QVOA and IPDA measurements were performed on 156 resting CD4 T-cell (rCD4) samples from 83 antiretroviral therapy-suppressed HIV-positive participants. Longitudinal QVOA and IPDA measurements were performed on rCD4 from 29 of these participants. RESULTS: Frequencies of intact, defective, and total proviruses were positively associated with frequencies of replication-competent HIV. Longitudinally, decreases in intact proviral frequencies were strikingly similar to that of replication-competent virus in most participants. In contrast, defective proviral DNA frequencies appeared relatively stable over time in most individuals. CONCLUSIONS: Changes in frequencies of IPDA-derived intact proviral DNA and replication-competent HIV measured by QVOA are similar. IPDA is a promising high-throughput approach to estimate changes in the frequency of the replication-competent reservoir.
引用
- Falcinelli SD, Kilpatrick KW, Read J, et al. Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy. J Infect Dis. 2021. PMID: 33216132. doi:10.1093/infdis/jiaa718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。